Parkwood LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-159,438
| Closed | -$11M | – | 97 |
|
|
2025
Q2 | $11M | Sell |
159,438
-303,133
| -66% | -$20.6M | 1.01% | 38 |
|
|
2025
Q1 | $32.1M | Buy |
462,571
+200,976
| +77% | +$16.6M | 3.14% | 3 |
|
|
2024
Q4 | $22.5M | Sell |
261,595
-2,385
| -0.9% | -$258K | 2.77% | 4 |
|
|
2024
Q3 | $31.4M | Buy |
263,980
+27,941
| +12% | +$3.73M | 3.82% | 6 |
|
|
2024
Q2 | $33.7M | Buy |
236,039
+61,245
| +35% | +$8.12M | 4.19% | 2 |
|
|
2024
Q1 | $22.4M | Buy |
174,794
+27,966
| +19% | +$3.33M | 2.34% | 6 |
|
|
2023
Q4 | $15.2M | Sell |
146,828
-22,186
| -13% | -$2.19M | 2.43% | 15 |
|
|
2023
Q3 | $15.4M | Buy |
169,014
+17,876
| +12% | +$1.57M | 2.73% | 8 |
|
|
2023
Q2 | $12.2M | Sell |
151,138
-47,634
| -24% | -$3.89M | 2.23% | 9 |
|
|
2023
Q1 | $15.8M | Buy |
198,772
+122,860
| +162% | +$8.71M | 2.94% | 8 |
|
|
2022
Q4 | $5.14M | Buy |
+75,912
| New | +$4.45M | 1.05% | 34 |
|
|
2022
Q3 | – | Sell |
-70,778
| Closed | -$3.94M | – | 172 |
|
|
2022
Q2 | $3.94M | Sell |
70,778
-114,952
| -62% | -$6.38M | 0.78% | 47 |
|
|
2022
Q1 | $10.3M | Buy |
185,730
+47,582
| +34% | +$2.44M | 1.71% | 12 |
|
|
2021
Q4 | $7.74M | Sell |
138,148
-2,490
| -2% | -$135K | 1.35% | 20 |
|
|
2021
Q3 | $6.75M | Sell |
140,638
-39,170
| -22% | -$1.89M | 1.14% | 29 |
|
|
2021
Q2 | $7.53M | Sell |
179,808
-1,904
| -1% | -$73.8K | 1.3% | 24 |
|
|
2021
Q1 | $6.13M | Buy |
181,712
+17,654
| +11% | +$629K | 1.08% | 28 |
|
|
2020
Q4 | $5.73M | Sell |
164,058
-22,996
| -12% | -$795K | 0.95% | 43 |
|
|
2020
Q3 | $6.49M | Buy |
187,054
+44,540
| +31% | +$1.48M | 1.17% | 29 |
|
|
2020
Q2 | $4.67M | Buy |
+142,514
| New | +$4.55M | 0.88% | 39 |
|
Other funds holding NVO
F
